Regional features in the treatment of Parkinson’s disease in the Baltic States compared to Germany
Paula Abola, Ligita Smeltere, Ruta Kaladyte Lokominiene, Georg Straeten, Karlheinz Reinfrank, Katrin Sikk, Pille Taba · 2026
Read Regional features in the treatment of Parkinson’s disease in the Baltic States compared to Germany by Paula Abola, Ligita Smeltere, Ruta Kaladyte Lokominiene, Georg Straeten, Karlheinz Reinfrank, Katrin Sikk, Pille Taba (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13312687.txt.
Description
Paula Abola and co-authors compare Parkinson's care in the three Baltic states against Germany, mapping how payment rules shape access. Their 2026 study uses a structured policy comparison across drugs, device-aided therapies, and rehabilitation. Advanced disease leans hard on health and payment systems.
Germany funds all three domains broadly, including newer drugs and structured rehab. Estonia and Lithuania fully cover standard drugs but ration device therapies and vary on rehab. Latvia lags most, with partial drug cover, no funded device therapy, and thin support services. Spending gaps track the access gaps. The authors argue rule design, not just wealth, decides what patients actually get.
Catalog record
| CREATOR | Paula Abola, Ligita Smeltere, Ruta Kaladyte Lokominiene, Georg Straeten, Karlheinz Reinfrank, Katrin Sikk, Pille Taba |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |